<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><meta name="exporter-version" content="Evernote Mac 7.14 (458244)"/><meta name="author" content="taylor.arhar@gmail.com"/><meta name="created" content="2019-06-21 23:15:03 +0000"/><meta name="source" content="desktop.mac"/><meta name="updated" content="2019-06-21 23:23:22 +0000"/><title>June 12, 2019</title></head><body><div>DnaJB1 purification day 2:</div><div>- GOAL: reverse purify out the TEV, then concentrate and purify by SEC200</div><div>- reverse TEV purification and concentration were performed as previously described</div><div>- success ofÂ TEV cleavage was assessed by SDS-PAGE (see attached); the amount/activity of TEV was not sufficient to cleave all of the purified DJB1</div><div>- DJB1 (concentrated to 5mL total) was injected onto SEC200 column, pre-equilibrated with 50mM Tris, 50mM NaCl, pH 8.0 running buffer (this is NOT the usual salt concentration of JDP buffer)</div><div>- SEC200 fractions were assessed by SDS-PAGE (see attached); due to unexpected high mol weight protein (or very possibly poor stain/destain of gel), fraction C7 was discarded</div><div>- RESULTS: some DJB1 was lost to incomplete TEV cleavage or aggregation, but a high proportion of DJB1 was isolated from dimer SEC200 peak at high purity</div><div><img src="June%2012,%202019.html.resources/2019-06-12%2016h05m05s%20Coomassie%20Blue(Coomassie%20Blue).tif" /><br/></div><div><br/></div><div><br/></div></body></html>
